Viewing Study NCT00447057

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-01-27 @ 6:03 AM
Study NCT ID: NCT00447057
Status: COMPLETED
Last Update Posted: 2011-10-13
First Post: 2007-03-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Pemetrexed Versus Pemetrexed Plus Erlotinib as Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Eli Lilly and Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Histological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None nonsquamous View